[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AstraZeneca Plc - Enterprise Tech Ecosystem Series

April 2021 | 20 pages | ID: A55CB4B8D568EN
GlobalData

US$ 1,495.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
AstraZeneca Plc - Enterprise Tech Ecosystem Series

SUMMARY

AstraZeneca Plc (AstraZeneca) is a developer, manufacturer, and marketer of prescription pharmaceuticals. The company provides drugs for various therapeutic areas, including oncology, cardiovascular, renal, and metabolic disease (CVRM), respiratory, and others.

AstraZeneca is implementing AI technology in order to gain better understanding of diseases, identify new targets for novel medicines, and enable its scientists to discover and develop new medicines.

AstraZeneca Plc (AstraZeneca) is a developer, manufacturer, and marketer of prescription pharmaceuticals. The company provides drugs for various therapeutic areas, including oncology, cardiovascular, renal, and metabolic disease (CVRM), respiratory, and others.

The report provides information and insights into AstraZeneca Plc's tech activities, including -
  • Insights of its digital transformation strategies and digital venture
  • Overview of technology initiatives covering partnerships and innovative solution launch
  • Insights on each technology initiative including technology theme, objective, and benefits
  • Details of estimated ICT budgets and major ICT contracts
SCOPE
  • AstraZeneca, along with 16 other partners launched Machine Learning Ledger Orchestration for Drug Discovery (MELLODDY), a new research consortium with the objective to leverage machine learning and accelerate drug discovery through a three-year project.
  • AstraZeneca is also a part of the Machine Learning for Pharmaceutical Discovery and Synthesis (MLPDS) consortium with participants from departments of chemistry, chemical engineering, and computer science at Massachusetts Institute of Technology, and 14 biotechnology and pharmaceutical companies.
  • The company continues to build its expertise in data management and analytics by strategic acquisitions and partnerships. AstraZeneca partnered with Talend to leverage its unified data integration suite to collect, govern, transform, and share the data hosted on AWS cloud architecture.
REASONS TO BUY
  • Gain insights into AstraZeneca Plc's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various technology introduction, adoption, and partnership strategies of AstraZeneca Plc.
Overview
Digital Transformation Strategy
R&D Centers, Innovation Hubs, and Accelerators
Technology Focus
Technology Initiatives
Partnership Network Map
ICT Budgets & Contracts
Key Executives
About GlobalData


More Publications